+20% units YoYHQ-led decisions

Liquivida

Health services

Software purchasing at Liquivida is controlled at the corporate level, with President and Founder Samael A. Tejada and VP of Operations Jessica Wright as likely decision-makers. The franchisor mandates Zenoti POS/EMR by Zenoti, Inc. across all locations. With 15 total units (12 franchised, 3 company-owned) and 20% year-over-year unit growth, the addressable market is small but expanding, concentrated in Florida, New Jersey, Texas, Arizona, and Wisconsin.

Mandated & recommended tech

The systems vendors compete with

1 of these are mandated in the franchise agreement. Each is named in Item 11 of the filing — the incumbents a challenger must displace or integrate with.

Zenoti POS/EMRZenoti, Inc.
Mandatory
POSItem 11

You must use the Zenoti POS/EMR computerized point-of-sale system

Live signals

Total units
15
12 franchised
Unit growth YoY
+20%
vs prior filing
AUV
$1.12M
Item 19, 2025
Royalty
6%
of gross sales
Ad fund
national + local
Initial fee
$75K
per unit
Investment range
$621K–$1.03M
all-in, Item 7
Procurement
Franchisor controlled
from the filing

The vendor opportunity at Liquivida

Liquivida operates a small but growing network of 15 health-services locations—12 franchised and 3 company-owned—across five states. The brand reported a 20% year-over-year unit growth rate in its 2025 FDD, signaling active expansion. Average unit volume sits at $1,123,575, with a 6% royalty rate and a 10-year initial franchise term. For software vendors, the immediate addressable market is 15 units, but the growth trajectory and renewal mechanics suggest future openings.

The operator footprint is entirely single-unit: 20 mapped operators, all in the 1-unit band, with no multi-unit operators on file. This means every location decision flows through a single owner-operator, but technology mandates come from the top. The top states are Florida (10 units), New Jersey (4), Texas (4), Arizona (1), and Wisconsin (1).

Who controls software purchasing

The 2025 FDD Item 1 lists five executives at Liquivida’s headquarters. Samael A. Tejada, President and Founder, is the ultimate authority. Jessica Wright, Vice President of Operations, is the most likely day-to-day decision-maker for operational software. Shayna Tejada handles finance and accounting operations, while Dr. Christopher J. Davis serves as Chief Medical Officer and Lisa Samela as Director of Operations. No dedicated IT or technology leadership role is disclosed, so any software pitch should address operational and financial stakeholders directly.

Because Liquivida mandates specific technology (see below), the buying center is centralized. Franchisees must adopt the mandated systems, so the sales motion is HQ-first. The absence of multi-unit operators reinforces this: no franchisee has enough scale to influence technology procurement independently.

Mandated and current tech stack

Liquivida mandates Zenoti POS/EMR by Zenoti, Inc. across all units, per Item 11 of the 2025 FDD. This is the sole named technology vendor in the disclosure. Zenoti serves as both point-of-sale and electronic medical records system, covering core operational workflows. For vendors selling complementary or replacement software, this is the incumbent to understand.

No other mandated or recommended systems are disclosed. The FDD does not list CRM, scheduling, marketing, HR, or financial software. This absence may represent white space for vendors whose tools integrate with or augment Zenoti’s capabilities. Any pitch should acknowledge the Zenoti mandate and position around it—either as an integration partner or as a superior alternative when renewal windows open.

Procurement, renewals, and timing

Item 8 of the 2025 FDD contains no extract regarding procurement. This means the franchisor does not publicly disclose a designated supplier list, approved vendor program, or purchasing cooperative in the FDD. In practice, this could indicate an open procurement model or simply a limited disclosure. Vendors should clarify directly with HQ whether there are informal preferred-vendor relationships not captured in the FDD.

Renewal timing offers a strategic entry point. The initial franchise agreement runs 10 years, with two optional 5-year renewal terms. To renew, franchisees must sign the then-current franchise agreement, which “may have materially different terms and conditions than your original Franchise Agreement,” and pay a renewal fee equal to the greater of 25% of the then-current initial franchise fee or $10,000. They must also execute a general release. These conditions create a natural re-evaluation moment: when a franchisee renews, the updated agreement could introduce new technology mandates or remove old ones. With 12 franchised units and a 10-year initial term, the first wave of renewals will begin roughly a decade after each unit’s opening, depending on the brand’s founding timeline.

How to read the Liquivida FDD

The 2025 Liquivida Franchise Disclosure Document is the authoritative source for vendor due diligence. Key sections include Item 1 (executives and corporate structure), Item 11 (mandated technology and suppliers), Item 8 (procurement restrictions, if any), and Item 17 (renewal and transfer conditions). The embedded PDF viewer below provides the full text. Use it to verify the executive roster, confirm the Zenoti mandate, and assess any updates to procurement language that may not be summarized here. For a ranked target list of franchise systems aligned with your software category, FranCloud can help.

Questions vendors ask

Liquivida, answered from the filing

The 2025 FDD lists Samael A. Tejada (President and Founder) and Jessica Wright (Vice President of Operations) as key executives. No dedicated CIO or CTO is named, so operational software decisions likely route through these roles.
Liquivida mandates Zenoti POS/EMR by Zenoti, Inc. for all franchise and company-owned locations, per Item 11 of the 2025 FDD.
Liquivida has 15 total units: 12 franchised and 3 company-owned. All 20 mapped operators are single-unit, with locations concentrated in FL (10), NJ (4), TX (4), AZ (1), and WI (1).
The 2025 FDD does not disclose a designated or approved supplier list in Item 8. The procurement model is not specified, suggesting either open purchasing or a limited disclosure.
The initial franchise term is 10 years, with two optional 5-year renewals. Renewal requires a fee (greater of 25% of the then-current initial franchise fee or $10,000) and a signed current agreement, which may have materially different terms, creating potential re-evaluation points.
The 2025 Liquivida FDD is filed with state franchise regulators. You can view the embedded PDF viewer below for full details on Item 1 executives, Item 11 tech mandates, and Item 17 renewal conditions.
Source

Read the filing itself

Every number on this page traces back to this document. Read it in full, page by page — buy the original PDF to download, search, and annotate it.

Liquivida2025 FDDView only
Buy the PDF — $149

Loading filing…

View only A one-time purchase — the original filing, yours to keep.

FDD alert

Tell me when this brand refiles.

We’ll email you the moment Liquivida files a new annual FDD — usually the freshest signal of a vendor change.

Sell software to franchises? See the playbook.

Your matched accounts, fit-scored to what you sell, with the contacts and openers built from each filing.

Find my accounts

Operator footprint

Who runs the locations

20 operators run 20 mapped locations — 0 of them are multi-unit. Aggregate counts from the filing; no names.

Operators by units owned

Single-unit20

Top states by locations

FL10
NJ4
TX4
AZ1
WI1

Related Health services brands

Primary franchise filings · updated June 2026. Every figure is source-traceable and QA-checked.